Job Posting: Research Scholar, Valve Science Center

An established cardiology research team led by Chair of Cardiothoracic Surgery, Vinayak N. Bapat, MBBS, MCh, FRCS.CTh invites applications for a full-time research scholar to join the Valve Science Center team for a period of two years. Our research team is based at the Minneapolis Heart Institute Foundation (MHIF) in Minneapolis, Minnesota, USA and works in collaboration with the Minneapolis Heart Institute® at Abbott Northwestern Hospital (MHI), part of the Allina Health System. We are seeking a highly motivated physician researcher who is interested in studying valvular heart disease and contributing to progress in the field to begin approximately August, 2024.

Top candidates enjoy and have experience in handling multiple projects and working independently as well as collaboratively in a research group. Using excellent written and oral English communication skills, scholars are expected to publish in peer-reviewed journals and present results at scientific conferences.

This postdoctoral training experience includes mentorship from multi- subspecialty Valve Science Center physicians and support from a scientific services team in developing a research program, writing research proposals and career development.

Key Responsibilities and experience gained include:

  • Under the oversight of several physician mentors, participate in the design, implementation, data analysis and presentation of multiple population research studies using scientific methods.
  • Prepare and submit abstracts to scientific congresses and present the work in oral and/or poster formats.  The second year of the program typically involves presentation of publication of multiple scientific studies with the Valve Science Research Scholar as lead author. 
  • Build experience and be mentored in medical writing and the publication process.
  • Participate in clinical observations; note: this research position has no patient care responsibilities.
  • Research focus areas will include aortic, mitral, and tricuspid valvular disease and interventions.


Duration: We will assist the chosen scholar in the acquisition of a research visa which is often granted in one-year increments. We are looking for a minimum commitment of 2 years full-time to optimize this training, education, research and publication experience.

Qualifications: Medical degree with track record of excellence. Completion of cardiology training is preferred but not required. Familiarity with state-of-the-art care in valvular and structural heart disease. Knowledge of scientific research methods, processes, and general familiarity with the design and execution of research protocols. Proficiency in English (verbal and written).  Possesses foundational skills in technology, including Excel, databases and PowerPoint. Experience working collaboratively in a team setting. 

Financial Support: Research scholar will receive a full-time salary and employee benefits, and relocation service assistance to identify housing, acquire a social security number, set up bank accounts, etc.   

Apply to join our talented 90+ person team:

Apply Here

Minneapolis Heart Institute Foundation is an EEO/Affirmative Action employer.

Date posted: March 12, 2024

Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.